JPMorgan lowered the firm’s price target on Thermo Fisher to $600 from $630 and keeps an Overweight rating on the shares. The company reported “mixed” Q3 results and lowered 2023 guidance as widely expected, but provided a disappointing initial 2024 framework that drove the stock down, the analyst tells investors in a research note. The firm believes Thermo is better positioned to navigate the near-term headwinds in the sector versus peers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher price target lowered to $524 from $589 at Baird
- Thermo Fisher price target lowered to $530 from $625 at Citi
- Thermo Fisher price target lowered to $475 from $585 at Barclays
- Thermo Fisher downgraded to Sector Weight from Overweight at KeyBanc
- Thermo Fisher Scientific Earnings Report: Did it Beat Expectations?